CSIMarket
 


Becton Dickinson And Company  (BDX)
Other Ticker:  
 
 

BDX's Net Cash Flow Growth by Quarter and Year

Becton Dickinson And's Net Cash Flow results by quarter and year




BDX Net Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter September - -48.00 - -244.00
III Quarter June - 525.00 -642.00 134.00
II Quarter March 451.00 1,831.00 - 126.00
I Quarter December 530.00 18.00 - -13,055.00
FY   981.00 2,326.00 -642.00 -13,039.00



BDX Net Cash Flow second quarter 2021 Y/Y Growth Comment
Becton Dickinson And Company reported drop in Net Cash Flow in the second quarter by -75.37% to $ 451.00 millions, from the same quarter in 2020.
The fall in the second quarter Becton Dickinson And Company's Net Cash Flow compares unfavorably to the Company's average Net Cash Flow doubling of 176.93%.

Looking into second quarter results within Medical Equipment & Supplies industry 37 other companies have achieved higher Net Cash Flow growth. While Becton Dickinson And Company' s Net Cash Flow meltdown of -75.37% ranks overall at the positon no. 963 in the second quarter.




BDX Net Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter September - - - -
III Quarter June - - - -98.99 %
II Quarter March -75.37 % - - -
I Quarter December 2844.44 % - - -
FY   - - - -

Financial Statements
Becton Dickinson And's second quarter 2021 Net Cash Flow $ 451.00 millions BDX's Income Statement
Becton Dickinson And's second quarter 2020 Net Cash Flow $ 1,831.00 millions Quarterly BDX's Income Statement
New: More BDX's historic Net Cash Flow Growth >>


BDX Net Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter September - - - -
III Quarter June - -71.33 % - 6.35 %
II Quarter March -14.91 % 10072.22 % - -
I Quarter December - - - -
FY (Year on Year)   - - - -




Net Cash Flow second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #176
Overall #963

Net Cash Flow Y/Y Growth Statistics
High Average Low
3308.49 % 176.93 % -98.38 %
(Sep. 30, 2008)   (Dec 31 2017)
Net Cash Flow second quarter 2021 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #176
Overall #963
Net Cash Flow Y/Y Growth Statistics
High Average Low
3308.49 % 176.93 % -98.38 %
(Sep. 30, 2008)   (Dec 31 2017)

Net Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Becton Dickinson And's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
10072.22 % 914.42 % -97.53 %
(Mar 31 2020)  


BDX's II. Quarter Q/Q Net Cash Flow Comment
In the II. Quarter 2021 Becton Dickinson And Company reported drop in Net Cash Flow sequentially by -14.91% to $ 451.00 millions, from $ 530.00 millions declared in the previous reporting period.

Although seasonal circumstance normally fuel II. Quarter 2021 Net Cash Flow, this simply was not sufficient to recover BDX's II. Quarter 2021 achievement, Patrick M. Campbell, Medical Equipment & Supplies industry contributor pointed out.

Within Medical Equipment & Supplies industry 10 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Becton Dickinson And's Net Cash Flow growth quarter on quarter, overall rank is 336.


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #11
Healthcare Sector #58
Overall #336
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #11
Healthcare Sector #58
Overall #336
Net Cash Flow Q/Q Growth Statistics
High Average Low
10072.22 % 914.42 % -97.53 %
(Mar 31 2020)  


BDX's II. Quarter Q/Q Net Cash Flow Comment
In the II. Quarter 2021 Becton Dickinson And Company reported drop in Net Cash Flow sequentially by -14.91% to $ 451.00 millions, from $ 530.00 millions achived in the previous quarter.

Although cyclical factors commonly elevate II. Quarter 2021 Net Cash Flow, this clearly has not been sufficient to recover Becton Dickinson And's II. Quarter achievement, Patrick M. Campbell, Medical Equipment & Supplies industry contributor said.

Within Medical Equipment & Supplies industry 10 other companies have achieved higher Net Cash Flow quarter on quarter growth. While Becton Dickinson And's Net Cash Flow growth quarter on quarter, overall rank is 336.


Becton Dickinson And's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Net Cash Flow 12 Months Ending $ 1,458.00 $ 2,838.00 $ 2,326.00 $ 3,016.00 $ 1,849.00
Y / Y Net Cash Flow Growth (TTM) -21.15 % - - - -
Year on Year Net Cash Flow Growth Overall Ranking # 388 # 0 # 0 # 0 # 0
Seqeuential Net Cash Flow Change (TTM) -48.63 % 22.01 % -22.88 % 63.12 % -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 963 # 284 # 1195 # 605 # 0




Cumulative Net Cash Flow growth Comment
Becton Dickinson And showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in Dec 31 2020. If the fiscal year would end in Mar 31 2021, Becton Dickinson And's annual Net Cash Flow rise would be -21.15% year on year to $1,458 millions.

In the Healthcare sector 71 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 388.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
3308.49 %
176.93 %
-98.38 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 72
Overall # 388

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
10701.71 %
1593.79 %
-78.97 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 176
S&P 500 # 963
Cumulative Net Cash Flow growth Comment
Becton Dickinson And showed decline, but improvement compare to trailing twelve month Net Cash Flow decrease in Dec 31 2020. If the fiscal year would end in Mar 31 2021, Becton Dickinson And's annual Net Cash Flow drop would be -21.15% year on year to $1,458 millions.

In the Healthcare sector 71 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Net Cash Flow growth total ranking has deteriorated compare to previous quarter from 0 to 388.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
3308.49 %
176.93 %
-98.38 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 38
Healthcare Sector # 72
Overall # 388

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
10701.71 %
1593.79 %
-78.97 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 38
Sector # 176
S&P 500 # 963




Other Net Cash Flow Growth
Medical Equipment & Supplies Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BDX's Net Cash Flow Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BDX's Competitors
Net Cash Flow Growth for Becton Dickinson And's Suppliers
Net Cash Flow Growth for BDX's Customers

You may also want to know
BDX's Annual Growth Rates BDX's Profitability Ratios BDX's Asset Turnover Ratio BDX's Dividend Growth
BDX's Roe BDX's Valuation Ratios BDX's Financial Strength Ratios BDX's Dividend Payout Ratio
BDX's Roa BDX's Inventory Turnover Ratio BDX's Growth Rates BDX's Dividend Comparisons



Companies with similar Net Cash Flow drop for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Mar 31 2021
Option Care Health Inc -0.89%$ -0.893 millions
Catalyst Biosciences Inc -4.20%$ -4.202 millions
Intra cellular Therapies Inc -4.67%$ -4.665 millions
Igm Biosciences Inc -7.14%$ -7.136 millions
Alector Inc -14.79%$ -14.790 millions
Myriad Genetics Inc -19.85%$ -19.849 millions
Inogen Inc -22.01%$ -22.015 millions
Verrica Pharmaceuticals Inc -26.15%$ -26.147 millions
Aclaris Therapeutics Inc -26.87%$ -26.868 millions
Biodelivery Sciences International Inc -27.85%$ -27.851 millions
Align Technology inc -28.90%$ -28.896 millions
United Therapeutics Corporation-31.58%$ -31.579 millions
Vertex Pharmaceuticals Inc-32.67%$ -32.667 millions
Syros Pharmaceuticals inc -35.91%$ -35.911 millions
Agenus Inc-35.92%$ -35.917 millions
Iradimed Corp-36.52%$ -36.522 millions
Assertio Holdings inc -36.98%$ -36.982 millions
Zymeworks Inc -37.89%$ -37.885 millions
Deciphera Pharmaceuticals Inc -39.86%$ -39.862 millions
Chiasma Inc -39.98%$ -39.980 millions
Nevro Corp -40.87%$ -40.865 millions
Xencor Inc-42.88%$ -42.880 millions
Vanda Pharmaceuticals Inc -44.17%$ -44.167 millions
Myomo Inc -44.61%$ -44.607 millions
Passage Bio Inc -44.93%$ -44.931 millions
Innoviva inc -50.73%$ -50.730 millions
Intricon Corporation-52.78%$ -52.782 millions
Enanta Pharmaceuticals Inc-52.91%$ -52.905 millions
Biomarin Pharmaceutical Inc-53.67%$ -53.670 millions
Transmedics Group Inc -53.81%$ -53.810 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BXG's Profile

Stock Price

BXG's Financials

Business Description

Fundamentals

Charts & Quotes

BXG's News

Suppliers

BXG's Competitors

Customers & Markets

Economic Indicators

BXG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071